The global CAR T-cell therapy market shows significant development in recent years. This movement is driven by the growing prevalence of cancer, advancements in treatment, and a rapid demand for effective treatment options. The market is estimated to arrive at a value of US\$XX billion by 20XX, with a yearly expansion rate of around XX%. Major sta